Analystreport

PDL BioPharma Inc (NASDAQ: PDLI) was upgraded by analysts at TheStreet from a "d+" rating to a "c-" rating.

PDL BIOPHARMA  (PDLI) 
Last pdl biopharma earnings: 3/11 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.pdl.com